China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS)

CNY 20.02

(-0.2%)

Total Debt Summary of China Resources Double-Crane Pharmaceutical Co.,Ltd.

  • China Resources Double-Crane Pharmaceutical Co.,Ltd.'s latest annual total debt in 2023 was 462.87 Million CNY , up 74.68% from previous year.
  • China Resources Double-Crane Pharmaceutical Co.,Ltd.'s latest quarterly total debt in 2024 Q3 was 665.46 Million CNY , up 156.24% from previous quarter.
  • China Resources Double-Crane Pharmaceutical Co.,Ltd. reported annual total debt of 264.99 Million CNY in 2022, up 308.3% from previous year.
  • China Resources Double-Crane Pharmaceutical Co.,Ltd. reported annual total debt of 64.9 Million CNY in 2021, up 878.17% from previous year.
  • China Resources Double-Crane Pharmaceutical Co.,Ltd. reported quarterly total debt of 665.46 Million CNY for 2024 Q3, up 156.24% from previous quarter.
  • China Resources Double-Crane Pharmaceutical Co.,Ltd. reported quarterly total debt of 269.49 Million CNY for 2024 Q2, down -13.39% from previous quarter.

Annual Total Debt Chart of China Resources Double-Crane Pharmaceutical Co.,Ltd. (2023 - 1994)

Historical Annual Total Debt of China Resources Double-Crane Pharmaceutical Co.,Ltd. (2023 - 1994)

Year Total Debt Total Debt Growth
2023 462.87 Million CNY 74.68%
2022 264.99 Million CNY 308.3%
2021 64.9 Million CNY 878.17%
2020 6.63 Million CNY -89.77%
2019 64.86 Million CNY -20.86%
2018 81.96 Million CNY 25344.09%
2017 322.11 Thousand CNY 0.0%
2016 - CNY -100.0%
2015 41.22 Million CNY 3278.69%
2014 1.22 Million CNY -99.42%
2013 210 Million CNY -28.81%
2012 295 Million CNY -26.39%
2011 400.74 Million CNY 36.87%
2010 292.8 Million CNY 5.32%
2009 278 Million CNY -18.59%
2008 341.5 Million CNY 9.81%
2007 311 Million CNY -2.35%
2006 318.5 Million CNY -55.88%
2005 721.89 Million CNY -18.85%
2004 889.53 Million CNY -17.62%
2003 1.07 Billion CNY 52.85%
2002 706.41 Million CNY 65.62%
2001 426.51 Million CNY 70.39%
2000 250.32 Million CNY 32.53%
1999 188.88 Million CNY 62.84%
1998 115.99 Million CNY 54.65%
1997 75 Million CNY 111.27%
1996 35.5 Million CNY 8775.0%
1995 400 Thousand CNY 0.0%
1994 - CNY 0.0%

Peer Total Debt Comparison of China Resources Double-Crane Pharmaceutical Co.,Ltd.

Name Total Debt Total Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 1.58 Billion CNY 70.759%
Yabao Pharmaceutical Group Co., Ltd 209 Million CNY -121.471%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 15.79 Billion CNY 97.069%
Harbin Pharmaceutical Group Co., Ltd. 3.55 Billion CNY 86.994%
Tasly Pharmaceutical Group Co., Ltd 2.95 Billion CNY 84.359%
Zhejiang Medicine Co., Ltd. 801.44 Million CNY 42.244%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 839.84 Million CNY 44.886%
Lionco Pharmaceutical Group Co.,Ltd. 565.61 Million CNY 18.163%
Humanwell Healthcare (Group) Co.,Ltd. 9.94 Billion CNY 95.347%
Ginwa Enterprise (Group) Inc. 10.77 Million CNY -4195.423%
Joincare Pharmaceutical Group Industry Co.,Ltd. 7.4 Billion CNY 93.746%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 175.68 Million CNY -163.466%
China Animal Husbandry Industry Co., Ltd. 1.45 Billion CNY 68.211%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 9.91 Million CNY -4570.776%
Zhejiang Huahai Pharmaceutical Co., Ltd. 7.45 Billion CNY 93.789%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.08 Billion CNY 57.243%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.3 Billion CNY 64.461%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 727.9 Million CNY 36.41%
Chongqing Taiji Industry(Group) Co.,Ltd 4.86 Billion CNY 90.478%
HPGC Renmintongtai Pharmaceutical Corporation 2.33 Billion CNY 80.161%
Nanjing Well Pharmaceutical Group Co.,Ltd. 486.95 Million CNY 4.945%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 995.24 Million CNY 53.491%
Henan Lingrui Pharmaceutical Co., Ltd. 149.26 Million CNY -210.101%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.2 Billion CNY 61.548%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.07 Billion CNY 57.105%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 48.13 Million CNY -861.624%
Zhongzhu Healthcare Holding Co.,Ltd 23.94 Million CNY -1833.339%
Beijing Tongrentang Co., Ltd 3.42 Billion CNY 86.492%
KPC Pharmaceuticals, Inc. 1.17 Billion CNY 60.48%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 17.28 Million CNY -2578.421%
North China Pharmaceutical Company Ltd. 11.72 Billion CNY 96.053%
Tibet Weixinkang Medicine Co., Ltd. 7.68 Million CNY -5925.379%
China National Medicines Corporation Ltd. 3.15 Billion CNY 85.341%
Zhejiang Hisun Pharmaceutical Co., Ltd. 5.69 Billion CNY 91.868%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.15 Billion CNY 85.309%
ChengDu ShengNuo Biotec Co.,Ltd. 267.22 Million CNY -73.219%
Dali Pharmaceuticalco.,Ltd 23.66 Million CNY -1856.164%
Changchun BCHT Biotechnology Co. 20.47 Million CNY -2161.028%
Zhejiang Shengda Bio-Pharm Co., Ltd. 238.44 Million CNY -94.127%
Shanghai Jiaoda Onlly Co.,Ltd 208.92 Million CNY -121.549%
Jiang Zhong Pharmaceutical Co.,Ltd 56.62 Million CNY -717.462%
Mayinglong Pharmaceutical Group Co., LTD. 380.42 Million CNY -21.674%
Cisen Pharmaceutical Co., Ltd. 170.67 Million CNY -171.206%
Hunan Warrant Pharmaceutical Co.,Ltd 24.18 Million CNY -1814.183%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 35.72 Billion CNY 98.704%
Jianmin Pharmaceutical Group Co.,Ltd. 501.17 Million CNY 7.642%
Hunan Fangsheng Pharmaceutical Co., Ltd. 679.7 Million CNY 31.9%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.78 Billion CNY 74.076%
Guobang Pharma Ltd. 963.26 Million CNY 51.947%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 659.05 Million CNY 29.766%
Kangmei Pharmaceutical Co., Ltd. 255.01 Million CNY -81.511%
Shandong Buchang Pharmaceuticals Co., Ltd. 3.4 Billion CNY 86.422%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.19 Billion CNY 85.496%
Henan Taloph Pharmaceutical Stock Co.,Ltd 819.3 Million CNY 43.504%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 116.7 Million CNY -296.619%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.62 Billion CNY 82.371%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 446.65 Million CNY -3.633%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.75 Billion CNY 73.551%
Shanghai Yizhong Pharmaceutical Co., Ltd. 44.02 Million CNY -951.325%
Tibet Rhodiola Pharmaceutical Holding Co. 501.52 Million CNY 7.705%
Sichuan Huiyu Pharmaceutical Co., Ltd. 435.5 Million CNY -6.285%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 443.84 Million CNY -4.289%
CanSino Biologics Inc. 2.71 Billion CNY 82.95%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 705.78 Million CNY 34.416%
Shandong Lukang Pharmaceutical Co.,Ltd. 3.43 Billion CNY 86.525%